Topics

Bristol Myers Squibb bags FDA approval of Zeposia for relapsing forms of multiple sclerosis https://www.firstwordpharma.com/node/1710854  $BMY

06:43 EDT 26 Mar 2020 | FirstWord Pharma

Bristol Myers Squibb bags FDA approval of Zeposia for relapsing forms of multiple sclerosis https://www.firstwordpharma.com/node/1710854 

Original Article: Bristol Myers Squibb bags FDA approval of Zeposia for relapsing forms of multiple sclerosis https://www.firstwordpharma.com/node/1710854  $BMY

NEXT ARTICLE

More From BioPortfolio on "Bristol Myers Squibb bags FDA approval of Zeposia for relapsing forms of multiple sclerosis https://www.firstwordpharma.com/node/1710854  $BMY"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...